Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7111779
[patent_doc_number] => 20050209235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'C-5 Modified indazolylpyrrolotriazines'
[patent_app_type] => utility
[patent_app_number] => 11/125021
[patent_app_country] => US
[patent_app_date] => 2005-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20094
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125021
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125021 | C-5 Modified indazolylpyrrolotriazines | May 8, 2005 | Abandoned |
Array
(
[id] => 7046224
[patent_doc_number] => 20050250819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Inhibitors of bacterial type III protein secretion systems'
[patent_app_type] => utility
[patent_app_number] => 11/124008
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18215
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250819.pdf
[firstpage_image] =>[orig_patent_app_number] => 11124008
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/124008 | Inhibitors of bacterial type III protein secretion systems | May 5, 2005 | Abandoned |
Array
(
[id] => 6931789
[patent_doc_number] => 20050282824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems'
[patent_app_type] => utility
[patent_app_number] => 11/124226
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19688
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282824.pdf
[firstpage_image] =>[orig_patent_app_number] => 11124226
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/124226 | Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems | May 5, 2005 | Abandoned |
Array
(
[id] => 7691405
[patent_doc_number] => 20070232628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Calcilytic Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/568709
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10187
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232628.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568709
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568709 | Calcilytic Compounds | May 2, 2005 | Abandoned |
Array
(
[id] => 7188398
[patent_doc_number] => 20050192306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Pyrimidine derivatives as selective inhibitors of COX-2'
[patent_app_type] => utility
[patent_app_number] => 11/119653
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4413
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119653 | Pyrimidine derivatives as selective inhibitors of COX-2 | May 1, 2005 | Abandoned |
Array
(
[id] => 4579523
[patent_doc_number] => 07834002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-16
[patent_title] => '4-amino-5-cyanopyrimidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/579067
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46328
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/834/07834002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579067
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579067 | 4-amino-5-cyanopyrimidine derivatives | Apr 27, 2005 | Issued |
10/533028 | Kinase inhibitors | Apr 25, 2005 | Abandoned |
Array
(
[id] => 7111805
[patent_doc_number] => 20050209261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Rho-kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/111704
[patent_app_country] => US
[patent_app_date] => 2005-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10117
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209261.pdf
[firstpage_image] =>[orig_patent_app_number] => 11111704
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/111704 | Rho-kinase inhibitors | Apr 21, 2005 | Abandoned |
Array
(
[id] => 583124
[patent_doc_number] => 07449474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-11
[patent_title] => 'Tri-substituted ureas as cytokine inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/111581
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13895
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449474.pdf
[firstpage_image] =>[orig_patent_app_number] => 11111581
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/111581 | Tri-substituted ureas as cytokine inhibitors | Apr 20, 2005 | Issued |
Array
(
[id] => 826923
[patent_doc_number] => 07402589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => 'Tri-substituted ureas as cytokine inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/111612
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28929
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402589.pdf
[firstpage_image] =>[orig_patent_app_number] => 11111612
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/111612 | Tri-substituted ureas as cytokine inhibitors | Apr 20, 2005 | Issued |
Array
(
[id] => 7051348
[patent_doc_number] => 20050187235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Pyrimidine derivatives useful as selective COX-2 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/110118
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6599
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110118
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110118 | Pyrimidine derivatives useful as selective COX-2 inhibitors | Apr 19, 2005 | Abandoned |
Array
(
[id] => 102727
[patent_doc_number] => 07723347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Substituted phenylamino-pyrimidines'
[patent_app_type] => utility
[patent_app_number] => 11/587630
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26607
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723347.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587630
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587630 | Substituted phenylamino-pyrimidines | Apr 13, 2005 | Issued |
Array
(
[id] => 5046615
[patent_doc_number] => 20070265289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => '2-Aminopyrimidine Derivative'
[patent_app_type] => utility
[patent_app_number] => 11/578608
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19624
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265289.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578608
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578608 | 2-Aminopyrimidine Derivative | Apr 12, 2005 | Abandoned |
Array
(
[id] => 7069076
[patent_doc_number] => 20050244459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Coating compositions for bioactive agents'
[patent_app_type] => utility
[patent_app_number] => 11/099997
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14151
[patent_no_of_claims] => 106
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244459.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099997
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099997 | Coating compositions for bioactive agents | Apr 5, 2005 | Abandoned |
Array
(
[id] => 569672
[patent_doc_number] => 07462619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Pyridazine, pyrimidine and pyrazine ethyne compounds'
[patent_app_type] => utility
[patent_app_number] => 11/097047
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15398
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097047
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097047 | Pyridazine, pyrimidine and pyrazine ethyne compounds | Mar 31, 2005 | Issued |
Array
(
[id] => 7188388
[patent_doc_number] => 20050192303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/095212
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42165
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192303.pdf
[firstpage_image] =>[orig_patent_app_number] => 11095212
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/095212 | Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds | Mar 30, 2005 | Issued |
Array
(
[id] => 7188311
[patent_doc_number] => 20050192295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/095361
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42111
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192295.pdf
[firstpage_image] =>[orig_patent_app_number] => 11095361
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/095361 | Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds | Mar 30, 2005 | Abandoned |
Array
(
[id] => 4786266
[patent_doc_number] => 20080139595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/547975
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19896
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139595.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547975
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547975 | Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors | Mar 29, 2005 | Issued |
Array
(
[id] => 569523
[patent_doc_number] => 07462612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Pyridine inhibitors of ERK2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/089701
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13354
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11089701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/089701 | Pyridine inhibitors of ERK2 and uses thereof | Mar 24, 2005 | Issued |
Array
(
[id] => 7005821
[patent_doc_number] => 20050171134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => '4,5-Disubstituted-2-aminopyrimidines'
[patent_app_type] => utility
[patent_app_number] => 11/090474
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14153
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171134.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090474
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090474 | 4,5-Disubstituted-2-aminopyrimidines | Mar 24, 2005 | Abandoned |